Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection
Hepatitis Research and Treatment · 2010
DOI: 10.1155/2010/495928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatitis Research and Treatment, 2010. Verfasst von Rie Kubota und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Practice and Sciences, Department of Clinical Pharmacy, Center for Clinical Pharmacy and Sciences, School of Pharmacy, Kitasato University, …. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Aims . To determine whether the erythrocyte phosphorylated ribavirin (RBV) level might be a useful index of EVR and risk of anemia and to determine the optimal dose of RBV in 24 patients with hepatitis C with pegylated interferon and RBV. Methodology . The RBV level was measured by a high-performance liquid chromatography. Results and Conclusion . In patients aged 50 years or over, a negative correlation (, ) was observed between the RBV level at week 2 and rate of Hb reduction () at week 4. The at week 4 was significantly greater in patients with RBV levels of ≥800 ( %) than in patients with RBV levels
Autor:innen und Institutionen
- Pharmacy Practice and Sciences, Department of Clinical Pharmacy, Center for Clinical Pharmacy and Sciences, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.
Zitieren
APA
Kubota, R., Komiyama, T., Kumagai, N., Kimijima, M., Mitsuki, K., Uetake, J., Kaneko, F., Tsunematsu, S., & Tsuchimoto, K. (2010). Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection. Hepatitis Research and Treatment. https://doi.org/10.1155/2010/495928
Vancouver
Kubota R, Komiyama T, Kumagai N, Kimijima M, Mitsuki K, Uetake J, et al. Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection. Hepatitis Research and Treatment. 2010. doi:10.1155/2010/495928
BibTeX
@article{Kubota2010,
author = {Kubota, Rie and Komiyama, Takako and Kumagai, Naoki and Kimijima, Miyuki and Mitsuki, Keiko and Uetake, Junko and Kaneko, Fumihiko and Tsunematsu, Satoshi and Tsuchimoto, Kanji},
title = {Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection},
journal = {Hepatitis Research and Treatment},
year = {2010},
doi = {10.1155/2010/495928}
}
EUVIMED